SCHEMBL93164

SCHEMBL93164

C1=NN=CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10239471 0.74
SCHEMBL2027890 0.71
SCHEMBL18669551 0.59
SCHEMBL2674228 0.47
SCHEMBL12992748 0.45
SCHEMBL2088 0.45
SCHEMBL2326 0.45
SCHEMBL6918 0.45
SCHEMBL1112761 0.41
Fluoride SCHEMBL11159332 0.41

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1625 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114805368-B Preparation method of pontinib 山东诺明康药物研究院有限公司 2023-12-01 CN claimed
EP-3655394-B1 NOVEL ALBICIDIN DERIVATIVES, THEIR USE AND SYNTHESIS UNIV BERLIN TECH (DE) 2023-11-22 EP claimed
US-20230330084-A1 HETEROARYL-KETONE FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS CORCEPT THERAPEUTICS, INC. (US) 2023-10-19 US claimed
US-20230167111-A1 OCTAHYDRO FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS CORCEPT THERAPEUTICS, INC. (US) 2023-06-01 US claimed
US-11648245-B2 Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators CORCEPT THERAPEUTICS, INC. (US) 2023-05-16 US claimed
EP-3848027-B1 OCTAHYDRO FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS CORCEPT THERAPEUTICS INC (US) 2023-04-05 EP claimed
EP-4119561-A1 HETEROARYL-KETONE FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS Corcept Therapeutics Incorporated (US) 2023-01-18 EP claimed
EP-4065230-A1 THERAPEUTIC COMPOUNDS Genentech, Inc. (US) 2022-10-05 EP claimed
US-11370789-B2 Octahydro fused azadecalin glucocorticoid receptor modulators CORCEPT THERAPEUTICS, INC. (US) 2022-06-28 US claimed
US-20210369701-A1 HETEROARYL-KETONE FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS CORCEPT THERAPEUTICS, INC. 2021-12-02 US claimed
US-4707478-A ANTIPROTOZOA AGENTS RORER PHARMACEUTICAL CORPORATION (US) 1987-11-17 US claimed
US-4701457-A Amidinoureas for treating irritable bowel syndrome RORER PHARMACEUTICAL CORPORATION (US) 1987-10-20 US claimed
EP-0086775-A4 HETEROCYCLIC AMIDINO SUBSTITUTED UREAS AND THEIR PHARMACEUTICAL USES. RORER INTERNAT OVERSEAS INC (US) 1984-09-05 EP claimed
US-4406897-A 6-Aryl-4-hydrazinyl-s-triazin-2-ones WILLIAM H. RORER, INC. (US) 1983-09-27 US claimed
EP-0086774-A1 TREATMENT OF COCCIDIAL INFECTIONS WITH AMIDINOUREA OR AMIDINOTHIOUREA DERIVATIVES RORER INTERNATIONAL (OVERSEAS) INC. (US) 1983-08-31 EP claimed
EP-0086775-A1 HETEROCYCLIC AMIDINO SUBSTITUTED UREAS AND THEIR PHARMACEUTICAL USES RORER INTERNATIONAL (OVERSEAS) INC. (US) 1983-08-31 EP claimed
EP-0079377-A1 HETEROCYCLIC ALKYLENE AMIDINOUREAS RORER INTERNATIONAL (OVERSEAS) INC. (US) 1983-05-25 EP claimed
WO-1983000625-A1 TREATMENT OF COCCIDIAL INFECTIONS WITH AMIDINOUREA OR AMIDINOTHIOUREA DERIVATIVES STUDT, WILLIAM, LYON 1983-03-03 WO claimed
WO-1983000627-A1 HETEROCYCLIC AMIDINO SUBSTITUTED UREAS AND THEIR PHARMACEUTICAL USES STUDT, WILLIAM, LYON 1983-03-03 WO claimed
WO-1982004048-A1 HETEROCYCLIC ALKYLENE AMIDINOUREAS RORER INT OVERSEAS (US) 1982-11-25 WO claimed